Compare NKTX & DAVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NKTX | DAVA |
|---|---|---|
| Founded | 2015 | 2000 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 198.2M | 159.1M |
| IPO Year | 2020 | 2015 |
| Metric | NKTX | DAVA |
|---|---|---|
| Price | $2.07 | $2.97 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 9 |
| Target Price | $11.33 | ★ $13.50 |
| AVG Volume (30 Days) | ★ 795.2K | 262.4K |
| Earning Date | 05-11-2026 | 05-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 11.88 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4.07 |
| P/E Ratio | ★ N/A | $20.02 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.70 | $2.55 |
| 52 Week High | $3.72 | $14.99 |
| Indicator | NKTX | DAVA |
|---|---|---|
| Relative Strength Index (RSI) | 29.92 | 50.14 |
| Support Level | $1.93 | $2.64 |
| Resistance Level | $2.22 | $3.03 |
| Average True Range (ATR) | 0.15 | 0.14 |
| MACD | -0.06 | 0.03 |
| Stochastic Oscillator | 3.68 | 42.31 |
Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK-cell expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.
Endava is a next-generation IT services company that primarily assists clients with their digital transformation efforts by creating customized software for them. The company was founded in 2006 in the UK, and it continues to generate the majority of revenue in the UK and Europe. Endava's client base is concentrated in the payments and financial services, technology, media, and telecom industries.